Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.62 USD | +0.23% | +1.17% | -19.62% |
05-09 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Oncternal Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.62% | 25.51M | |
+27.69% | 49.18B | |
+0.81% | 42.11B | |
+50.01% | 40.37B | |
-5.26% | 28.85B | |
+12.81% | 26.09B | |
-21.79% | 18.71B | |
+10.08% | 13.26B | |
+31.35% | 12.32B | |
+0.14% | 11.99B |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- Brookline Capital Downgrades Oncternal Therapeutics to Hold From Buy